Helicobacter hepaticus infection of A/JCr mice is a model of infectious liver cancer. We monitored hepatic global gene expression profiles in H. hepaticus infected and control male A/JCr mice at 3 months, 6 months, and 1 year of age using an Affymetrix-based oligonucleotide microarray platform on the premise that a specific genetic expression signature at isolated time points would be indicative of disease status. Model based expression index comparisons generated by dChip yielded consistent profiles of differential gene expression for H. hepaticus infected male mice with progressive liver disease versus uninfected control mice within each age group. Linear discriminant analysis and principal component analysis allowed segregation of mice based on combined age and lesion status, or age alone. Up-regulation of putative tumor markers correlated with advancing hepatocellular dysplasia. Transcriptionally down-regulated genes in mice with liver lesions included those related to peroxisome proliferator, fatty acid, and steroid metabolism pathways. In conclusion, transcriptional profiling of hepatic genes documented gene expression signatures in the livers of H. hepaticus infected male A/JCr mice with chronic progressive hepatitis and preneoplastic liver lesions, complemented the histopathological diagnosis, and suggested molecular targets for the monitoring and intervention of disease progression prior to the onset of hepatocellular neoplasia.
INTRODUCTION
Microbial causes of enterohepatic cancer are well known. Helicobacter pylori infection is the single greatest risk factor for gastric adenocarcinoma and has been classified a class I carcinogen by the World Health Organization . Liver cancer in humans is associated with hepatitis B and C virus infection. Similarly, Helicobacter spp. may potentiate inflammation and risk of hepatocellular carcinoma (HCC) in humans with or without viral hepatitis (Ponzetto et al., 2000) . Infection-associated inflammation is widely recognized as a contributor to human HCC and cholangiocarcinoma (Fox et al., 1998; Avenaud et al., 2000; Nilsson et al., 2001) .
Helicobacter hepaticus is associated with chronic hepatitis and HCC in A/JCr and other susceptible mouse strains, including A × B recombinant inbred mice, B6C3F1 mice and B6AF1 mice (Fox et al., , 1996b Ward et al., 1994; Hailey et al., 1998; Ihrig et al., 1999) . A/JCr mice infected with H. hepaticus develop necrogranulomatous lob-ular and/or lymphocytic portal hepatitis. Male mice are more susceptible to hepatitis and tumors than females. For reasons that are not clear, only a subset of H. hepaticus-infected male mice are affected (Fox et al., 1996b) . In the present study, we monitored by microarray analysis chronological changes in hepatic gene expression due to H. hepaticus-induced chronic hepatitis in the preneoplastic phase. We compared gene expression profiles in H. hepaticus-infected male A/JCr mice with severe liver disease to uninfected mice and to infected nondiseased mice at 3 months, 6 months, and 1 year of age. Unique gene expression signatures obtained from the microarray analysis allowed us to segregate H. hepaticusinfected diseased liver from H. hepaticus-infected diseasefree livers and uninfected controls. Furthermore, the gene expression profiles allowed segregation of liver profiles based on age of the mice. This study provides for the first time a chronological transcriptional characterization of a microbially induced progressive inflammation of the liver resulting in preneoplastic liver lesions.
MATERIALS AND METHODS Animals
Viral antibody free and Helicobacter free A/JCr mice were purchased from the National Cancer Institute. Helicobacter free status was confirmed by fecal PCR analysis as described elsewhere (Rogers et al., Toxicologic Pathology, this issue) . Mice housing, food, water, bedding, lighting cycle and other environmental conditions, and euthanasia were as described (Rogers et al., Toxicologic Pathology, this issue) in an animal facility approved by the Association for the Assessment and Accreditation of Laboratory Animal Care, International (Rockville, MD) . All experiments complied with the "Guide for the Care and Use of Laboratory Animals" prepared by the National Institutes of Health and were approved by the Committee on Animal Care at the Massachusetts Institute of Technology (MIT).
Helicobacter hepaticus Infection
The infection and bacterial colonization methods are discussed in detail elsewhere (Rogers et al., Toxicologic Pathology, this issue) . H. hepaticus type strain ATCCC 51488 was grown on TSA 5% sheep blood agar (Remel, Lenexa, KS) under microaerobic conditions (N 2 , H 2 , and CO 2 ; 90:5:5) for 2 days and transferred with a sterile applicator to 1.5 ml of Brucella broth. This was immediately deposited into 150 ml of Brucella broth in a flask, enclosed in an BBL GasPak 100 polycarbonate anaerobic jar (Becton Dickison Microbiology Systems, Cockeysville, MD) under microaerobic conditions, and placed on a PsychroTherm incubator-shaker table (New Brunswick Scientific Co., Edison NJ) at 30 RPM at 37 • C overnight. Approximately 10 8 bacteria/ml were placed in phosphate buffered saline (PBS) for one dose. Bacterial count was confirmed by a reading of 1.0 at 660 nm on a DuPro 640 spectrophotometer (Beckman Coulter, Fullerton, CA). Bacterial viability, motility, and morphology were confirmed by phase-contrast microscopy.
Helicobacter-free A/JCr mice were bred, and a subset of pregnant dams orally inoculated with Helicobacter hepaticus or vehicle only intragestationally as described elsewhere (Rogers et al., Toxicologic Pathology, this issue) . Additional groups were inoculated or rechallenged at 3-weeks or 12 weeks postnatally. Mice were euthanized by CO 2 inhalation at 3, 6, or 12 months of age. DNA was extracted from feces and frozen liver sections using a commercial kit (DNeasy Tissue Kit, Qiagen, Carlsbad, CA). Samples positive for H. hepaticus-specific DNA by nested polymerase chain reaction (PCR), as well as uninfected negative controls, were quantitated by real-time fluorogenic PCR (TaqMan) as described (Rogers et al., Toxicologic Pathology, this issue) .
Histopathology
At necropsy, samples of each liver lobe were collected for histopathology. Lesions were evaluated histologically as described elsewhere (Rogers et al., Toxicologic Pathology, this issue) .
Liver Samples
Samples were sections of the left liver lobe of A/JCr mice (Mus musculus). Sections of the liver were used for histology and total RNA isolation. Total RNA was used for microarray and quantitative real-time fluorogenic PCR assays. Mouse liver was aseptically removed immediately after CO 2 euthanasia and placed in an individual cryogenic vial (Corning, NY). The cryogenic vial was immediately placed in the vapor phase of liquid nitrogen. At the end of the necropsy for the total experiment, the cryogenic vials were transferred to a −80 • C freezer.
Representative samples at 3, 6, and 12 months from 18 male mice were selected for microarray analysis based on known infection status and presence or absence of hepati-tis as demonstrated by histopathology. Biological replicates representing 2 uninfected mice, 2 infected mice without significant liver lesions, and 2 infected mice with severe hepatitis were analyzed at each time point. Samples for microarray analysis were selected from groups of pups born to dams inoculated during pregnancy with subsequent H. hepaticus inoculation of pups at 3 weeks postnatally (Rogers et al., Toxicologic Pathology, this issue) . H. hepaticus-infected litterand cagemates with and without hepatitis were chosen for direct comparison whenever possible.
RNA Isolation and Quality Assessment
The standard protocols followed were per Affymetix's instructions (Genechip Expression Analysis Technical Manual 701021 Rev 4). Briefly, total RNA was isolated from 2 sections (each approximately 35 mg) of flash frozen liver using Trizol (Invitrogen, Carlsbad, CA) as per manufacturer's instructions. The RNA pellet was resuspended in 100 ul of RNAse free water. The RNeasy Clean-up kit (Qiagen, Valencia, CA) was utilized per manufacturer's instructions resulting in 30 ul total RNA sample. The total RNA concentration and 260/280 ratio was evaluated on a NanoDrop ND-1000 UV-Vis Spectrophotomter (NanoDrop Technologies, Rockland, DE). Only samples with a 260/280 ratio greater than 1.9 were further processed. An aliquot of 1 ul from each of the samples was diluted to be within the dynamic range of the Agilent RNA 6000 Nano Labchip kit (Agilent, Palo Alto, CA), with a target of 100 ng. The Nano Labchip protocol was followed as per manufacturer's instructions and was placed on an Agilent 2100 Bioanalyzer (Agilent, Palo Alto, CA) for evaluation. Samples with the highest concentration, only 2 distinct 18 S and 28 S peaks, and no evidence of degradation were further processed.
To obtain 15 µg of total RNA for first strand cDNA synthesis, samples were sometimes combined and placed on a spinvacuum to obtain the necessary concentration (1.66 µg/µl) and volume (9 µl). Six hundred units of SuperScript II reverse transcriptase were used for the first strand cDNA synthesis reaction. Half of the samples were prepared at the Division of Comparative Medicine at MIT and the other half of the samples were prepared at the Whitehead Institute (JAL) for comparison. The second strand DNA synthesis, the clean-up of the double-stranded cDNA, the synthesis of the biotin-labeled cRNA, and the clean-up of the biotin-labeled cRNA were per Affymetrix instructions. The Genechip Sample Cleanup module was used for the clean-up steps of the doublestranded cDNA and the biotin-labeled cRNA. Quantification of the cRNA was evaluated on the NanoDrop. Samples were used for hybridization only if 20 µg of cRNA were obtained in an individual sample or by combining samples.
Array Design
Affymetrix Murine Genome Arrays U74Av2. (Affymetrix, Santa Clara, CA) Array size: Standard Format. Feature size 20 µm. Sensitivity: 1:100,000. See www.affymetrix.com for the probe sequences or reference sequence from which the probe was derived. Microarrays were hybridized overnight, washed in a fluidics station, and scanned using the GeneArray scanner per manufacturer's instructions (Affymetrix, Santa Clara, CA). The U74Av2 oligonucleotide array contained ∼6,000 functionally characterized gene sequences (Unigene TOXICOLOGIC PATHOLOGY Murine Database, Build 74) and a similar number of expressed sequence-tagged (EST) clusters. There were 16-20 pairs of 25-mer oligonucletide probes per sequence, with a sensitivity of ∼1:100,000. Control sequences on the microarray included bioB, bioC, bioD, and cre, and housekeeping genes considered were actin, GAPDH, and hexokinase.
Hybridization
Fragmentation, hybridization, washing, staining, and scanning were done according to the Affymetrix protocol. Briefly, reagent preparation included 12X MES stock (1.22 M MES, 0.89 M [Na + ]) and 2X hybridization buffer (1X hybridization buffer: 100 mM MES, 1 M [Na + ], 20 mM EDTA, 0.01% Tween 20). The hybridization cocktail components and final concentrations consisted of fragmented cDNA (.05 µg/µl), control oligonucleotide B2 (50 pM), 20X eukaryotic hybridization controls bioB, bioC, bioD, and cre (1.5, 5, 25, 100 pM, respectively), herring sperm DNA (.1 mg/ml), acetylated BSA (.5 mg/ml), 1X hybridization buffer with a final volume of 300 µl. The GeneChip array was filled with 250 µl of the hybridization cocktail and hybridized for 16 hours, rotated at 60 RPM, and maintained at 45 • C.
Reagents prepared for washing and staining included a nonstringent wash buffer (6X SSPE, .01% Tween 20), a stringent wash buffer (100 mM MES, 0.1 M [Na + ], 0.01% Tween 20), and a 2X stain buffer (1X: 100 mM MES, 1 M [Na + ], 0.05% Tween 20). The wash procedure was carried out in an Affymetrix Fluidics Station 400 controlled by Affymetrix Microarray Suite 5.0 software resident on a personal computer. The fluidics station first went through a priming step and subsequently did the washing and staining by a software protocol designed for the Affymetrix Murine Genome Array U74Av2.
Measurements
The microarrays were scanned using the GeneArray scanner per manufacturer's instructions (Affymetrix, Santa Clara, CA). The quality control algorithms for eliminating an array are based on recommendations in both the Affymetrix and dChip software packages.
Normalization
For dChip software, an invariant-set normalization method is used (Li and Hung Wong, 2001a; Li and Wong, 2001b) . Briefly, the expectation is that a probe of a nondifferentially expressed gene in 2 arrays will have similar intensity ranks in 2 separate arrays. The ranks are calculated separately in the two arrays. Although it is unknown which genes are nondifferentially expressed, an iterative procedure is used to determine rank differences with an empirically derived threshold for inclusion. All arrays are normalized, except the baseline array, to the common baseline array with median intensity.
Data Analysis
Two software packages were utilized for data analysis, dChip (Li and Hung Wong, 2001a; Li and Wong, 2001b) and Affymetrix Microarray Suite 5.0. Microarray Suite 5.0 was used to generate a cell intensity file ( * .cel). The * .cel file and the perfect match model (PM) were used for the dChip analysis and is the data presented. The dChip software is model based, and generates a "model based expression index" (MBEI) and a standard error. The software utilizes the response characteristics of individual probe sets. Unless otherwise specified, default settings were used. Comparison analysis, hierarchical clustering, linear discriminant analysis (LDA), and principal component analysis (PCA) within dChip were performed. Comparison analysis used the default setting of 1.2-fold change, positive or negative. For hierarchical clustering, default settings were used, the distance metric was 1-correlation and the linkage was centroid.
Quantitative Real-Time Flurogenic PCR (Taqman)
To confirm microarray data, quantitative real-time flurogenic PCR was utilized. Assay-on-Demand gene expression kits (Applied Biosystems, Foster City, CA) were used to quantitate cytochrome P450 4a14 (Cyp4a14), interferon γ -induced GTPase (Igtp), H19 fetal liver mRNA (H19), hydroxysteroid dehydrogenase-5, delta 5 -3-beta (Hsd3b5), CD5 antigen-like (Cd5l) (formerly known as apoptosis inhibitor 6), trefoil factor 3, intestinal (Tff3) genes were normalized against the expression of glyceraldehyde 3 phosphate dehydrogenase (Gapdh) as the housekeeping standard. Two µg of total RNA from the uninfected and infected A/JCr mouse liver samples was reverse-transcribed to single strand cDNA using the Superscript Reverse Transcriptase II (Invitrogen, Carlsbad, CA) protocol. The single strand cDNA from the reverse transcriptase reaction was amplified by real-time quantitative flourogenic PCR. Eighty µl of 1X TE was added to the 20 µl reaction volume. The Taqman protocol was per manufacturer's instructions for the Applied Biosystems 7700 Sequence Detection System except that 25 µl total volume was used. The reaction consisted of the Taqman Universal 2X PCR Master Mix (12.5 ul), 5 ul of the cDNA/1XTE solution, 20X target (1.25 µl) and 6.25 µl of water. That RNA expression level fold changes were calculated as described by the Taqman protocol.
RESULTS

Histopathology
Briefly, the lobular hepatitis appeared at 3 months and the severity of lobular hepatitis did not worsen noticeably over the 12-month observation period. The lobular hepatitis was comprised of Kupffer cells and recruited macrophages, and was accompanied by hepatocellular coagulative necrosis. Unlike the lobular hepatic lesions, portal hepatitis was progressive over the 12-month study period. Portal hepatitis was manifest as either well-defined aggregates of mononuclear cells or locally invasive lesions that disrupted the hepatic limiting plate. Known precursor lesions to hepatocellular carcinoma including clear and tigroid cell foci and nodules of altered hepatocytes were most evident at the 12-month time point in male mice with lobular hepatitis. H. hepaticus DNA levels and hepatic histologic activity were positively correlated in infected H. hepaticus A/JCr male mice at the 12-month time point. Complete histopathology results are presented elsewhere (Rogers et al., Toxicologic Pathology, this issue) . (3, 6, 12) Microsome (3) Acute-phase response (3, 6, 12) Chemokine activity (6, 12) Immune response (3, 6, 12) Electron transport (6, 12) Cell surface (3, 6, 12) Integral to plasma membrane (6, 12) Membrane (3, 6, 12) Lipid transporter activity (6, 12) Integral to membrane (3, 6, 12) Inflammatory response (6) Antigen presentation, endogenous antigen (3, 6, 12)
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Transporter activity (12) Peptidase activity (3, 6) Structural constituent of ribosome (12) sponding to the immune response and the pathogen response. Group 3 again intersects most of Group 1 and Group 2, but new entries indicate tubulin, microtubule, cytoskeletal, peroxisome, scavenger, and structural and proliferative activity. Table 7 lists specific genes in the Gene Ontology categories of cell proliferation, growth, and death. Genes expressed during fetal development or imprinted genes are also evident in Group 3.
Genes Up-Regulated and Down-Regulated
Age matched H. hepaticus infected mice with progressive disease, exhibiting altered gene expression as defined by dChip software with default settings (Li and Wong, 2001b ), yielded 188 differentially expressed genes at 3 months, 401 at 6 months, and 678 at 12 months. Immune response genes, including the acute phase response, (6) Immunoglobulin, C-type (6, 12) Small chemokine, C-X-C subfamily (6, 12) Tubulin family (12) Tyrosine protein kinase, active site (12) FIGURE 1.-Simplified Venn diagram representation of clusters of hepatic differential gene expression, gene categories, and protein domains arising during the course of the H. hepaticus experimental infection of male A/JCr mice. Group 1 figuratively represents the acute phase of lobular hepatitis observed histologically throughout the course of the experiment due to persistent infection. Group 2 intersects Group 1 and additionally represents the maturation of inflammatory response and the portal hepatitis first recognized at 6 months that became progressively more severe. Group 3 intersects Group 1 and Group 2 and additionally represents tubulin, microtuble, scavenger, peroxisome, and structural gene categories, plus genes suggestive of hepatic preneoplasia. histocompatibility, macrophage, T and B cell development, and complement represented most of the up-regulated genes at 3 months (Table 1) . These genes continued to be upregulated throughout the 12-month experiment. The acute phase lipocalin family and serum amyloid family are represented in this group. At 6 months, there was a further increase in expression of these genes plus new differential expression levels of genes suggestive of further inflammatory response and repair including chemokine ligands (such as lymphocyte attracting chemokines Cxcl9 and Cxc13), chemokine receptors of the CC motif, ADAM family members, lysozyme, procollagen, cellular retinol binding protein (Lepreux et al., 2004) , and detoxification enzymes.
At 12 months post H. hepaticus infection, new genes upregulated represented more structurally related genes and more detoxification genes including tubulin, growth factors, carriers, and cytochrome P450 genes. Genes historically linked to neoplasia and up-regulated in the 12 month group included H19, intestinal trefoil factor 3, the ras family, and Jun-B. Up-regulated genes predominated over downregulated genes at all time points for H. hepaticus infected A/J mice with hepatic lesions. Interestingly, the vast majority of down-regulated genes were at 12 months (Table 2) . Down-regulated genes at 12 months were associated with steroid hormones, heme metabolism, and sodium/bile acid cotransport (Fraser et al., 2003; Jung et al., 2004) . There was a consistent segregation of the most highly up-regulated and select down-regulated genes for H. hepaticus-infected mice with lesions. Genes up-regulated or down-regulated at 12 months, along with their corresponding values at 3 and 6 months are exhibited in Tables 1 and 2, respectively.
Gene Ontology Clusters
Gene ontology www.geneontology.org describes gene products in 3 structured controlled vocabularies related to biological process, cellular components, and molecular functions. Microarray analysis generated multiple biological process ontology clusters for hepatic lesions of H. hepaticus infected A/JCr mice at all 3 time points (Table 3) . There were several biological processes involved over the entire 12-month time period pertaining to an active infection including gene products associated with the defense response, immune response, acute phase response, antigen presentation and processing, MHC receptor activity, lysosomes, and others represented in Table 3 . At 6 months post-H. hepaticus infection, the 3-month inflammatory biological processes were maintained and a chemokine activity cluster was added. Gene products associated with electron transport and lipid transport demonstrated increased activity (Table 3) . At 12 months, new clusters of biological processes indicated gene products involved with structural change, increased signal transduction, and peroxisome organization (Table 3) . 
Protein Domain Clusters
Protein domain clusters produced via microarray analysis indicated regulatory proteins and systems involved during H. hepaticus pathogenesis (Table 4 ). These domains often mediate interactions of regulatory protein construction or have enzymatic activity (Pawson and Nash, 2003) . As with the gene ontology clusters, some protein domain clusters were involved throughout the 12-month experimental period and were immunoglobulin related ( Table 4 ). The immunoglobulin C-type protein domain involvement began at 6 months, as did chemokine and serum amyloid protein interactions (Table 4) . At 12 months, structural activity promoted by tubulin domains was evident (Table 4) .
Immune Response Gene Expression
The individual genes members of the immune response biological process and their differential response at 3, 6, and 12 months are presented in Table 5 . Four hundred and sixteen genes are members of this gene ontology biological process category. Table 5 genes include individual histocompatibility, chemokine, serum amyloid, and complement, and confirm the gene category clusters and protein domain clusters results.
Pathogen Response Gene Expression
The Gene Ontology pathogen response biological process category consists of 241 genes and is a subcategory of the immune response. The individual genes and their differential response at 3, 6, and 12 months are presented in Table 6 . This pattern of individual chemokine, immunoglobulin, acute phase, and complement genes change expression putatively due to H. hepaticus infection. 
Cell Proliferation, Growth, and Death
Gene ontology categories suggestive of preneoplasia were investigated and included cell proliferation, cell growth, and cell death ( Table 7) . Some of the genes, as would be expected, suggest inflammatory cell turnover. Other genes do not necessarily fit into the inflammatory category including two oncogenes, the Kirsten rat sarcoma oncogene 2 (K-ras) and the Jun-B oncogene, that were slightly up-regulated 12 months postinfection.
Microarray Model Validation
Microarray results were tightly correlated (r > 0.99 for controls and r > 0.97 for mice with lesions) between biological replicates (individual mouse liver per array) (Figure 2A ). There was a moderate correlation between infected male mice that did not develop significant disease and uninfected controls ( Figure 2C) . In contrast, the correlation lessened substantially (r < 0.83) between infected mice that developed severe disease and uninfected controls (Figure 2D) . These results confirm that histologic assessment of lesion severity is reflected by global gene expression profile alterations, represented by all the genes not on the linear scatterplot as seen in Figure 2D . These genes have differential expression as compared to the controls in Figure 2A .
Differential Gene Expression for Aging
The experimental design enabled comparisons of transcription profiles due to aging. Aging control mice yielded Vol. 32, No. 6, 2004 H. HEPATICUS LIVER MICROARRAY 685 FIGURE 2.-Scatterplots highlighting variable degrees of correlation between microarray results from different groups of male A/JCr mice at 12 months. (a) High correlation between biological replicates (r > 0.99). (b) H. hepaticus-infected mice that did not develop disease are better correlated with shaminfected controls (r > 0.97). (c) than with infected diseased mice. (d) Marked discorrelation between infected mice with disease and sham-infected controls (r > 0.79). 402 differentially expressed genes at 6 months versus 3 months, 675 at 12 months versus 3 months, and 437 at 12 months versus 6 months. Although a large number of genes were associated with aging, the magnitude of hepatic expression differences was small (−6 to +10). Additional aging results are presented under linear discriminant analysis and principal component analysis.
Hierarchical Clustering
Hierarchical clustering allowed age-matched A/JCr mice pairs with lesions to be differentiated from controls. The dChip option of combined hierarchical clustering of mouse microarray samples and genes produced very similar "heatmap" patterns between mouse microarray sample pairs within 6 groups, with each group displaying a different pattern (Figure 3) . The increasing intensity of red (green) in the heatmap indicates an increasing (decreasing) expression level. The mice groups are labeled at the top of each column of the heatmap and consisted of the following pairs of arrays:
(1) 3-month controls (3u1, 3u2) (u: uninfected), (2) 6-month controls (6u1, 6u2) (3) 12-month controls (12u1, 12u2), (4) 3 month H. hepaticus-infected A/J mice with lesions (3L1, 3L2) (L: lesions), (5) 6 month H. hepaticus-infected A/J mice with lesions (6L1, 6L2), and (6) 12 month H. hepaticusinfected A/J mice with lesions (12L1, 12L2) ( Figure 3) .
Linear Discriminant Analysis and Principal Component Analysis
Linear discriminant analysis also differentiated between controls and H. hepaticus-infected A/J mice with hepatic TOXICOLOGIC PATHOLOGY lesions (Figure 4) . The control mice and the mice with hepatic lesions occupied opposite sides of the plot. Principal component analysis provided even more powerful classification of A/JCr mice groups. This algorithm produced regions of different ages for controls and for age groups of H. hepaticusinfected A/J mice with lesions ( Figure 5 ). However, these clear demarcations occurred only when the analysis omitted the transcription profile data for infected mice without lesions. Therefore, the LDA and PCA did not clearly differentiate the infection status of the mice when the livers were histologically normal at 3 and 6 months, but did indicate differences at 12 months postinfection (data not shown). Vol. 32, No. 6, 2004 H. HEPATICUS LIVER MICROARRAY 687 
Microarray Result Verification by Quantitative Real-Time RT-PCR
The Assay on Demand results validated the Affymetrix microarray values except for 2 data points where fold changes were less than 2 for both methods (Figure 6 ). transcription profiles at 3, 6, and 12 months that were indicative of the progressive liver disease illustrated by histopathology. The progressive severity of hepatitis and dysplasia in infected mice was associated with an increasing number of differentially expressed genes and a specific transcription profile. The gene expression signature of agematched controls and age-matched infected mice with lesions could be differentiated from each other utilizing hierarchical clustering and principal component analysis. Whether the hepatic transcription profile can be used to identify the age at infection, the time postinfection, and the temporal course of the molecular pathogenesis will require additional study.
DISCUSSION
Microarray analysis of the livers of H. hepaticus-infected
The gene expression signature complements histopathology and PCR techniques and aids in diagnosis and prognosis for this experimental infection.
Whether another strain of H. hepaticus, a different liver pathogen, or other liver insult yields a unique gene expression signature over time in various strains of mice is under investigation. Recent studies indicate a specific gene signature for virally induced HCC (Iizuka et al., 2004) . Many of the same differentially expressed genes in mice infected with H. hepaticus have also been documented in other models of murine hepatic injury and hepatic tumor promotion (Nyska et al., 1997; Graveel et al., 2001; Meyer et al., 2003) . Some studies suggest the transcription profile of a small set of highly up-regulated or down-regulated genes are indicative of a particular disease while other studies indicate even very modest changes in a larger set of genes and pathways are suggestive of a specific disease (Etzioni et al., 2003; Mootha et al., 2003a) .
Genes Associated with Neoplasia and Proliferation
Two putative tumor markers, H19 fetal liver mRNA and intestinal trefoil factor 3 (Table 1) , were increasingly upregulated over time in mice with progressive hepatocellular dysplasia. Despite its name, the endproduct of the H19 gene is considered a nonmessenger polyadenylated RNA molecule (Brannan et al., 1990) . H19 has putative regulatory roles in normal development, hepatocyte proliferation, and in oncogenesis (Kaplan et al., 2003; Yamamoto et al., 2004) . H19 shares the nonprotein coding property with a rapidly growing number of novel transcripts, and recent experiments indicate that as much as an order of magnitude more chromosomal DNA is transcribed than accounted for by currently predicted and characterized exons (Kapranov et al., 2002) . H19 is an imprinted gene with maternal allele expression. Loss of imprinting is a recognized human cancer risk, including genes H19, insulin-like growth factor 2 (Igf2), and cyclin dependent kinase inhibitor 1C (p57, KIP, CDK1NC) (Brannan and Bartolomei, 1999; Vernucci et al., 2000; Kaplan et al., 2003) . H19 and Igf2 are reciprocally imprinted, with Igf2 being expressed from the paternal allele (Vernucci et al., 2000) .
Igf2 is an anti-apoptotic factor associated with hepatocarcinogenesis, and is putatively activated and regulated by H19 (Vernucci et al., 2000) . Although Igf2 up-regulation was not observed at 12 months by microarray analysis, there was nearly 2-fold down-regulation of the Igf2 receptor (Table 2) , and an inverse relationship has been observed between epidermal growth factor and its cognate TOXICOLOGIC PATHOLOGY FIGURE 6.-Microarray (Affymetrix) result validation with RT-PCR (Assay on Demand). Rank invariant normalization to a baseline microarray was used for the microarray results (dChip). Normalization to GAPDH is used for the quantitative real-time RT-PCR. receptor in mice infected with H. hepaticus (Ramljak et al., 1998) . Insulin-like growth factor 1 (Igf1) is an acute phase protein that is decreased in plasma serum levels during systemic responses to inflammation (Gabay and Kushner, 1999) . Insulin-like growth factor binding protein 1 (Igfbp1) ( Table 1) was highly up-regulated in H. hepaticus-infected A/JCr mice at 12 months with liver lesions and foci of altered hepatocytes.
Igfbp1 binds both Igf1 and Igf2 with high affinity. Igfbp1 putatively functions as a critical survival factor in the liver by suppressing the level and activation of specific proapoptotic factors via its regulation of integrin-mediated signaling (Leu et al., 2003) . Igf1 is important in fetal growth and development (along with Igf2, the imprinted gene described previously). Igf1 is expressed predominantly in the liver, and targeted gene knockout results in embryonic lethality in mice (Le Roith et al., 1999; Yakar et al., 1999; Scharf et al., 2001) . Intestinal trefoil factor 3 is associated with enterohepatic inflammation, gastric cancer, colon cancer, pancreatic cancer, and breast cancer (Al-azzeh et al., 2002; Kimura et al., 2002; Leung et al., 2002; Katoh, 2003; Khan et al., 2003; Rodrigues et al., 2003) . This factor promotes epithelial cell migration and mucosal restitution during inflammation, and is differentially expressed in primary biliary cirrhosis (Kimura et al., 2002) .
Cyclin D1 is overexpressed in many human and murine tumors Parker et al., 2003) . Cyclin D1 (Ccnd1) affects G1 and was slightly up-regulated. Cyclin-dependent kinase inhibitor 1A (p21) (Cdkn1a) was also slightly up-regulated (Table 7) . It maintains the G2 checkpoint and, after DNA damage, can arrest cells in G2. Cytolethal distending toxin (CDT) in several Helicobacter spp. including H. hepaticus causes cell cycle arrest in the G2/M phase resulting in cell distension in selected cell culture lines (Young et al., 2000; Taylor et al., 2003) . An isogenic mutant of H. hepaticus lacking CDT activity when inoculated into C57BL/6 IL-10 −/− produced less inflammatory bowel disease (IBD) when compared to its wildtype counterpart (Young et al., 2004) . In another isogenic CDT mutant study, wild-type Campylobacter jejeuni infected NF-κB deficient mice exhibited a moderately severe gastritis and proximal duodenitis at 4 months postinfection while C. jejeuni CDT mutant infected NF-κB deficient mice were consistently cleared of C. jejeuni at 4 months postinfection. These results suggest CDT plays a role in inflammation and potentially participates in avoiding the immune response .
In addition to CDT's possible role in inflammation, dChip analysis indicates cytoskeletal organization effects by H. hepaticus, possibly in part due to CDT activity in the liver. Vol. 32, No. 6, 2004 H. HEPATICUS LIVER MICROARRAY 689 Protein domain clusters associated with tubulin (Table 3) and gene category clusters associated with structural constituents of the cytoskeleton, structural molecule movement, and microtubules are evident at 12 months (Table 4) . CDT reportedly damages DNA via its CdtB subunit, a homologue of mammalian type I Dnase. CDT has putative nuclear localization signals and may induce apoptosis through activation of caspase 2 and caspase 7 (Lara-Tejero and Galan, 2000; McSweeney and Dreyfus, 2004; Ohara et al., 2004) . Caspase 3 and caspase 2 were slightly upregulated in this study, but caspase 7 was not. Two oncogenes, K-ras and Jun-B, were slightly upregulated at 12 months post H. hepaticus infection. The ras family, K-ras, N-ras, and H-ras are guanine nucleotide binding proteins involved in cell proliferation, differentiation, and survival (Chan et al., 2004) . K-ras mediates cytokine signaling in formation of E-cadherin based adherens junctions in hepatocyte development (Matsui et al., 2002) . Jun-B suppresses cell proliferation through its inhibition of activation protein transcription factor (AP-1), however overexpression of Jun-B putatively perpetuates undifferentiated cancers (Song et al., 2004) . LPS from gram-negative bacteria induces AP-1, but there was no differential expression of any of the subunits of the AP-1 complex in this study. Mutations and increased expression in these genes have been reported in myeloproliferative disease, colon cancer, breast cancer, prostate cancer, and metastases to the liver (Matsui et al., 2002; Edwards et al., 2003; Frasor et al., 2003; Palmer et al., 2003; Chan et al., 2004; Selvamurugan et al., 2004; Song et al., 2004) . Although K-ras mutations have been reported in chemically induced hepatocellular carcinoma in the A/J mouse (Bai et al., 2003) , K-ras, H-ras, and N-ras mutations have not been reported in A/J mice infected with H. hepaticus Sipowicz et al., 1997b) . These data, indicating that H. hepaticus is nongenotoxic, are further documentation that H. hepaticus is acting as a tumor promoter.
Genes Associated with Inflammation
Chronic inflammation is a risk factor for cancer, and acute-phase proteins indicative of ongoing inflammation persisted at high levels over time in H. hepaticus-infected male mice with progressive disease (Gabay and Kushner, 1999; Rogers and Fox, 2004) . One acute-phase protein, lipocalin 2 (Table 1) , was prominently up-regulated in the liver as a result of H. hepaticus infection. Lipocalin 2 is highly expressed in hepatocellular carcinoma via genotoxic or peroxisomal mechanisms and the lipocalin family is expressed in other forms of cancer including pancreatic, colorectal, and ovarian (Bartsch and Tschesche, 1995; Nielsen et al., 1996; Furutani et al., 1998; Bratt, 2000) . Lipocalin 2 (Lpn2, uterocalin, 24p3, NGAL, SIP24) was discovered as a secreted, inducible protein from BALB/c 3T3 cells (Nilsen-Hamilton et al., 1982) and later identified as a product of mouse 24p3 mRNA and as an acutephase protein (Liu and Nilsen-Hamilton, 1995) . Lipocalin 2 in the Gene Ontology system is considered a transporter. Reported roles of lipocalin 2 include mucosal immunity, epithelial development in the kidney, signaling, transport of non-transferrin-bound iron, chaperoning, apoptosis, retinol transport, prostaglandin synthesis, and male scent expression (Cavaggioni and Mucignat-Caretta, 2000; Xu and Venge, 2000; Devireddy et al., 2001; Tong et al., 2003; Yang et al., 2003) . Other lipocalins, up-regulated in this study include orosomucoid and retinol-binding protein. Other acute-phase proteins were up-regulated in H. hepaticus-infected male A/JCr mice with severe disease. For example, serum amyloid A (Tables 4 and 5) is a hallmark indicator of active inflammation, and putatively activates neutrophils in addition to direct antimicrobial properties Ribeiro et al., 2003) . Also up-regulated was properdin factor (Table 5 ), a member of the alternative complement pathway of the innate immune system which binds to microbial surfaces. Ceruloplasmin, a plasma metalloprotein, binds copper and is involved in transferrin peroxidation. Haptoglobin protects against microbial growth by binding hemoglobin and preventing microbial access to iron (Eaton et al., 1982) . Hemopexin binds heme and transports it to the liver for iron recovery.
Genes Associated with Cytochrome P450
As seen in other rodent and human studies of hepatic injury, H. hepaticus infection in male A/JCr resulted in altered expression of several members of the cytochrome P450 (CYP) family. At 3 months, CYP2c37, 4a10, and 4a14 were down-regulated (Table 2) while CYP2b10 was up-regulated (Table 1) . At 6 months, CYP2c37, 4a10, 4a14, 51, and 7b1 were down-regulated (Table 2) . At 12 months, the previously listed group remained down-regulated (Table 2) while CYP2b9, 2b10, and 2b13 were up-regulated (Table 1) . Phenobarbital also up-regulates Cyp2b10 (Rivera-Rivera et al., 2003; Yoshinari et al., 2003) . Phenobarbital promotes hepatic tumors initiated by compounds such as N -nitrosodiethylamine (NDMA) (Thirunavukkarasu and Sakthisekaran, 2003) . This data is consistent with the hypothesis that H. hepaticus is a tumor promoter in the mouse liver initiated by NDMA Sipowicz et al., 1997b) . Members of the cytochrome P450 family are integral to detoxification, and play key roles in steroid, lipid, and bile acid metabolism. Reactive oxygen species are postulated to contribute to DNA damage and tumorigenesis, and electrophilic cytochrome P450 molecules are a major source of these highly reactive radicals (Bondy and Naderi, 1994) . Oxidative DNA damage including increased 8-hydroxydeoxyguanosine adducts have been reported in H. hepaticus-infected A/JCr mice, along with alterations in glutathione S-transferase and CYP2a5 (Chomarat et al., 1997; Sipowicz et al., 1997a) . It has been noted, however, that CYP2a5 induction may not be dependent on oxidative damage alone given reactive oxygen species are also produced in liver injury caused by LPS, which results in CYP2a5 downregulation (Bautista and Spitzer, 1990) .
Genes Associated with Steroids
The male predominance of HCC in humans suggests sex steroid involvement but epidemiological studies of serum levels have been controversial (Kuper et al., 2001; Tanaka et al., 2000) . Therapeutic trials of steroid receptor inhibitors on patients with diagnosed HCC yielded mixed results (Nowak et al., 2004) . One gene prominently and consistently downregulated (Table 2) in H. hepaticus-infected male A/JCr mice with severe hepatitis and preneoplastic liver lesions was hydroxysteroid dehydrogenase-5, delta 5 -3-beta (Hsd3b5). TOXICOLOGIC PATHOLOGY This 3-ketosteroid reductase gene, expressed only in the male mouse liver after puberty, reduces dihydrotestosterone to the relatively inactive 3β,17β-androstanediol, in preparation for conjugation and elimination (Payne et al., 1997) . Hsd3b5 is also down-regulated in the liver of mice exposed to peroxisome proliferators and genotoxins .
Genes Associated with Aging
Splicing factor 3b subunit 1 (Sf3b1), a subunit of the spliceosome complex; peroxisome proliferation-activated receptor alpha (Ppara), a transcription factor involved in regulation of fatty acid oxidation, glycerol metabolism, and amino acid metabolism in the liver (Kersten et al., 2001; Patsouris et al., 2004) ; pre-B cell colony enhancing factor 1 (Pbef1), a growth factor for early stage B cells and recently identified as an inflammatory cytokine affecting neutrophil apoptosis (Jia et al., 2004) ; and D site albumin promoter binding protein (Dbp), a liver enriched transcription factor, were up-regulated greater than 5-fold at 12 months of age versus 3 months of age. Syndecan (Sdc4), a heparan sulfate proteoglycan promotes focal adhesion and stress fibers and delays healing and impairs angiogenesis when deleted in mice (Echtermeyer et al., 2001; Keum et al., 2004) ; and tubulin beta 2 (Tubb2) were down-regulated by 5-fold. Although there were few genes substantially up-regulated or down-regulated with aging, the principal component analysis graph spatially clustered regions of age groups at 3, 6, and 12 months in the A/JCr mouse. Aging may be associated with slight but coordinated changes in gene expression over time, implying that coregulated groups of genes or pathways may be modified more predictably as a group pattern change rather than individual gene changes. Future analysis should examine this approach (Mootha et al., 2003b) . For example, aging is associated with an increased level of inflammation, and the present analysis confirms inflammation-associated genes being differentially expressed, but few individual genes change substantially over the course of 12 months. It is interesting to note that some genes such as insulin-like growth factor binding protein 1 (Igfbp1), apoptosis inhibitor 6 (now named CD5 antigenlike (Cd5l)), lysozyme (Lyzs), complement component 1 subcomponents (C1qa, C1qb, C1qg), tubulin beta 2 (Tubb2), Ia associated invariant chain (Ii), lipoprotein lipase (Lp1), and vascular cell adhesion molecule (Vcam1) are up-regulated due to H. hepaticus related lesions but are down-regulated with aging. In the aggregate, however, aging down-regulates more genes than it up-regulates in this study and others (Cao et al., 2001) .
Similar Studies Analyzing Gene Expression in H. hepaticus Infected A/JCr Mice
H. hepaticus initially colonizes the lower bowel before migrating to the liver. Although infection generally results in minimal-to-moderate inflammation in the lower bowel in immunocompetent mice, this murine pathogen induces severe typhlocolitis and lower bowel cancer in mutant mice with targeted immune dysfunctions Tomczak et al., 2003; Rogers and Fox, 2004) . In an H. hepaticus infection study in A/JCr mice, a cDNA array consisting of 1176 genes demonstrated 31 up-regulated and 2 down-regulated genes in the cecum at 3 months postinfection (Myles et al., 2003) . Some up-regulated genes in common in both studies at the 3 month time point included Ia associated invariant chain (Ii), interferon gamma inducible protein (Ifi47), and chemokine (CXC motif) ligand 9 (Cxcl9), and several different serum amyloid A components. Opioid receptor sigma 1 (Oprs1) was slightly up-regulated at 12 months in the present study. Continued study of host responses to H. hepaticus in the lower bowel may help identify factors responsible for protection or susceptibility to typhlocolitis as well as H. hepaticus translocation to the liver.
Hepatic proliferation is a key component of the development of HCC in the livers of mice infected with H. hepaticus (Fox et al., 1996a; Hailey et al., 1998) . In agreement with a previous study of H. hepaticus infection in 6-18month-old mice, we documented increased transcription of cyclin D1 and decreased epidermal growth factor receptor 2 in mice with progressive hepatic disease (Ramljak et al., 1998) . However, our microarray results did not confirm previously reported differences in other genes including c-myc, cyclindependent kinase 4, hepatocyte growth factor, and transforming growth factor-α (Ramljak et al., 1998) . Further studies are required to determine the contribution of different cell proliferation pathways related to tumorigenesis and their transcriptional, translational, and posttranslational regulatory mechanisms.
Summary
In summary, we characterized time-dependent gene expression signatures in the H. hepaticus infected A/J mouse liver with progressively severe liver disease. Transcription profiles in the livers of H. hepaticus-infected male A/JCr mice exhibiting liver lesions yield a consistent ranking of differentially expressed genes. Importantly, the bimodal distribution of disease severity in infected male mice, as demonstrated by histopathology, corresponds with global hepatic gene expression differences. The reasons for the variable H. hepaticus colonization density and disease susceptibility in males, however, remain unexplained. There was an increased number of genes exhibiting differential expression for aging mice, in both H. hepaticus-infected A/JCr mice and controls. Two putative tumor markers, intestinal trefoil factor 3 and H19 fetal liver mRNA were up-regulated in progressively dysplastic livers. Further investigations will determine if the gene expression signature of a target organ is diagnostic of a specific pathogen and whether there is prognostic value in data derived from this type of analysis. Global gene expression profiling by microarray analysis will continue to play an important role in elucidating molecular events in preneoplasia and cancer induced by microbial agents.
